Sera Prognostics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Sera Prognostics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Salt Lake City
- Headquarters state / province
- Utah
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SERA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001534969
- EIN
- 26-1911522
Board of directors
-
Gregory C. Critchfield · DirectorSince 2023
-
Jane F. Barlow · DirectorSince 2023
-
Jeffrey Thomas Elliott · DirectorSince 2025
-
Joshua Phillips · DirectorSince 2023
-
Kim P. Kamdar · DirectorSince 2023
-
Mansoor Raza Mirza · DirectorSince 2023
-
Marcus Dean Wilson · DirectorSince 2024
-
Mark Christopher Capone · DirectorSince 2026
-
Ryan Trimble · DirectorSince 2023
-
Sandra Aj Lawrence · DirectorSince 2023
-
Zhenya Lindgardt · Director · Chief Executive OfficerSince 2023
Chief executives
Zhenya Lindgardt
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
76.1%
-
97.4%
Board connections
4 of this board's directors also sit on 6 other boards.
- via Sandra Aj Lawrence
- via Sandra Aj Lawrence
- via Jeffrey Thomas Elliott
- via Mansoor Raza Mirza
- via Mark Christopher Capone
- via Jeffrey Thomas Elliott
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $649,962
- 53 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Anderson Dyaarl Lee Jr. Officer (Chief Commercial Officer) | Open-market sale | −1,800 | $2.00 | $3,600 |
| Sep 10, 2026 | Inglis Tiffany Eul Davis Officer (Chief Medical Officer) | Open-market sale | −486 | $2.00 | $972 |
| Sep 10, 2026 | Jackson Benjamin Officer (General Counsel) | Open-market sale | −2,190 | $2.00 | $4,380 |
| Sep 10, 2026 | Zhenya Lindgardt Director, Officer (Chief Executive Officer) | Open-market sale | −7,022 | $2.00 | $14,044 |
| Sep 8, 2026 | Zhenya Lindgardt Director, Officer (Chief Executive Officer) | Open-market sale | −20,139 | $2.00 | $40,278 |
| Aug 31, 2026 | Gleason Scott Officer (Chief Financial Officer) | Grant or award | +117,924 | — | — |
| Jul 10, 2026 | Jane F. Barlow Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Gregory C. Critchfield Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Mark Christopher Capone Director | Grant or award | +42,404 | — | — |
| Jul 10, 2026 | Kim P. Kamdar Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Sandra Aj Lawrence Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Mansoor Raza Mirza Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Joshua Phillips Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Jane F. Barlow Director | Grant or award | +1,949 | — | — |
| Jul 10, 2026 | Gregory C. Critchfield Director | Grant or award | +1,594 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.